Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Literature
1.
Ikeda K, Ogawa Y, Takii M, Sugano K, Ikeya T, Tokunaga S, et al. A role for elastography in the diagnosis of breast lesions by measuring the maximum fat lesion ratio (max-FLR) by tissue Doppler imaging. Breast Cancer. 2012;19:71–6.CrossRefPubMed
2.
Havre RF, Waage JR, Gilja OH, Odegaard S, Nesje LB. Real-time elastography: strain ratio measurements are influenced by the position of the reference area. Ultraschall Med. 2011;. doi:10.​1055/​s-0031-1273247.
3.
Zhi H, Xiao XY, Yang HY, Wen YL, Ou B, Luo BM, et al. Semi-quantitating stiffness of breast solid lesions in ultrasonic elastography. Acad Radiol. 2008;15:1347–53.CrossRefPubMed
Metadata
Title
Measuring of the maximum fat lesion ratio
Authors
Fuat Ozkan
Mehmet Fatih Inci
Murvet Yuksel
Publication date
01-07-2013
Publisher
Springer Japan
Published in
Breast Cancer / Issue 3/2013
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-012-0370-1

Other articles of this Issue 3/2013

Breast Cancer 3/2013 Go to the issue

Letter to the Editor

Autologous fat grafting: an innovative solution for the treatment of post-mastectomy pain syndrome

Original Article

Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer

Original Article

The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone

Original Article

Influence of the in situ component in 389 infiltrating ductal breast carcinomas

Original Article

The role of chemoradiotherapy in patients with unresectable T4 breast tumors

Case Report

Ductal carcinoma in situ with isolated tumor cells in the sentinel lymph node in a 17-year-old adolescent girl
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits